1. Kang R, Goodney PP, Wong SL. Importance of cost-effectiveness and value in cancer care and healthcare policy. Journal of Surgical Oncology. 2016;114(3):275-80.
7. Zon RT, Frame JN, Neuss MN, Page RD, Wollins DS, Stranne S, et al. American society of clinical oncology policy statement on clinical pathways in oncology. Journal of Oncology Practice. 2016;12(3):261-6. PMID:
26759491
8. Gautam S, Sylwestrzak G, Barron J, Chen X, Eleff M, Debono D, et al. Results from a health insurer's clinical pathway program in breast cancer. Journal of Oncology Practice. 2018;14(11):e711-21. PMID:
30321101
9. Malin JL. Charting the Course: Charting the course: Use of clinical pathways to improve value in cancer care. Journal of Clinical Oncology. 2020;38(4):367-71. PMID:
31804871
11. Ong WL, Schouwenburg MG, Van Bommel AC, Stowell C, Allison KH, Benn KE, et al. A standard set of value-based patient-centered outcomes for breast cancer: the International consortium for health outcomes measurement (ICHOM) initiative. The Journal of the American Medical Association Oncology. 2017;3(5):677-85.
12. Vitug AF, Newman LA. Complications in breast surgery. Surgical Clinics of North Americ. 2007;87(2):431-51. PMID:
17498536
13. Panhofer P, Ferenc V, Schutz M, Gleiss A, Dubsky P, Jakesz R, et al. Standardization of morbidity assessment in breast cancer surgery using the Clavien Dindo Classification. International Journal of Surgery. 2014;12(4):334-9. PMID:
24486930
15. Health Insurance Review and Assessment Service [Internet]. Gangwon-State, Korea: Health Insurance Review and Assessment Service; 2023;[cited 2023 May 15]. Available from:
http://www.hira.or.kr/co/search.do.
16. Kim HS, Kim SO, Kim BS. Use of a clinical pathway in laparoscopic gastrectomy for gastric cancer. World Journal of Gastroenterology. 2015;21(48):13507-24.
19. Lopez Bernal J, Cummins S, Gasparrini A. The use of controls in interrupted time series studies of public health interventions. International Journal of Epidemiology. 2018;47(6):2082-93. PMID:
29982445
20. Ministry of Health and Welfare. Korea Central Cancer Registry. National Cancer Center. [Publication number 11-1352000-000145-10] Annual Report of Cancer Statistics in Korea in 2019. Ilsan, Korea: Ministry of Health and Welfare; Korea Central Cancer Registry. National Cancer Center. 2022.
21. Rotter T, Kinsman L, James E, Machotta A, Gothe H, Willis J, et al. Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database of Systematic Reviews. 2010;(3.
23. Jackman DM, Zhang Y, Dalby C, Nguyen T, Nagle J, Lydon CA, et al. Cost and Survival Analysis Before and After Implementation of Dana-Farber Clinical Pathways for Patients With Stage IV NonSmall-Cell Lung Cancer. Journal of Oncology Practice. 2017;13(4):e346-52. PMID:
28260402
24. Hofmann PA. Critical path method: an important tool for coordinating clinical care. The Joint Commission Journal on Quality Improvement. 1993;19(7):235-46. PMID:
8401809